Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis

Mycopathologia

Volumn 163, Issue 4, 2007, Pages 191-202

  Aquino, Valério R ^a   Goldani, Luciano Z ^b   Pasqualotto, Alesssandro C ^c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aspergillosis; Bone marrow transplantation; Galactomannan; Invasive fungal infections; Solid organ transplantation

Indexed keywords

BIOLOGICAL MARKER; GALACTOMANNAN; MANNAN;

ANIMAL; ASPERGILLOSIS; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LABORATORY DIAGNOSIS; MOUSE; ORGAN TRANSPLANTATION; RABBIT; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; ASPERGILLOSIS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MANNANS; MICE; ORGAN TRANSPLANTATION; RABBITS; SENSITIVITY AND SPECIFICITY;

ASPERGILLUS; FUNGI;

EID: 34247267097     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-007-9010-2     Document Type: Review

References (88)

1. Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, Bennett JE, Walsh TJ, Patterson TF, Pankey GA. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000;30:696-709.
2. Bhatti Z, Shaukat A, Almyroudis NG, Segal BH. Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients. Mycopathologia 2006;162:1-15.
3. Klont RR, Mennink-Kersten MA, Verweij PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 2004;39:1467-74.
4. Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, van Eldere J, Verbist L, Boogaerts M. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999;37:3223-8.
5. Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995;33:497-500
6. Latge JP, Kobayashi H, Debeaupuis JP, Diaquin M, Sarfati J, Wieruszeski JM, Parra E, Bouchara JP, Fournet B. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun 1994;62:5424-33.
7. Bahia MC, Vieira RP, Mulloy B, Hartmann R, Bergter EB. The structures of polysaccharides and glycolipids of Aspergillus fumigatus grown in the presence of human serum. Mycopathologia 1997;137:17-25.
8. Mennink-kersten MASH, Ruegebrink D, Klont RR, Blijlevens NMA, Donnelly JP, Verweij PE. Improved detection of circulating Aspergillus antigen using a new pre-treatment procedure. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington DC, USA; 2005.
9. Kappe R, Schulze-Berge A. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol 1993;31:2489-90.
10. Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997;35:257-60.
11. Mennink-kersten MASH, Ruegebrink D, Klont RR, Verweij PE. Release of galactofuranose antigens by different Aspergillus species. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington DC, USA; 2005: Abstract M-153.
12. Hope WW, Kruhlak MJ, Lyman CA, Petraitiene R, Petraitis V, Francesconi A, Kasai M, Mickiene D, Sein T, Peter J, Kelaher AM, Hughes JE, Cotton MP, Cotten CJ, Bacher J, Tripathi S, Bermudez L, Maugel TK, Zerfas PM, Wingard JR, Drusano GL, Walsh TJ. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis 2007;195:455-66.
13. Becker MJ, de Marie S, Willemse D, Verbrugh HA, Bakker-Woudenberg IA. Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol 2000;38:1434-8.
14. Kauffman HF, Beaumont F, Meurs H, van der Heide S, de Vries K. Comparison of antibody measurements against Aspergillus fumigatus by means of double-diffusion and enzyme-linked immunosorbent assay (ELISA). J Allergy Clin Immunol 1983;72:255-61.
15. Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of Aspergillus in BAL. Chest 2002;121:1171-6.
16. McWhinney PH, Kibbler CC, Hamon MD, Smith OP, Gandhi L, Berger LA, Walesby RK, Hoffbrand AV, Prentice HG. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis 1993;17:397-404.
17. Bretagne S, Costa JM, Marmorat-Khuong A, Poron F, Cordonnier C, Vidaud M, Fleury-Feith J. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol 1995;33:1164-8.
18. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:654-62.
19. Becker MJ, Lugtenburg EJ, Cornelissen JJ, van der Schee C, Hoogsteden HC, de Marie S. Galactomannan detection in computerized tomography-based bronchoalveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003;121:448-57.
20. Lombardi G, Farina C, Andreoni S, d'Antonio D, Faggi E, Manso E, Mazzoni A. Multicenter evaluation of an enzyme immunoassay (Platelia Aspergillus) for the detection of Aspergillus antigen in serum. Mycopathologia 2002;155:129-33.
21. Ansorg R, heintschel von Heinegg R, Rath PM. Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 1994;13:582-9.
22. Hopwood V, Johnson EM, Cornish JM, Foot AB, Evans EG, Warnock DW. Use of the Pastorex Aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J Clin Pathol 1995;48:210-213.
23. Verweij PE, Latge JP, Rijs AJ, Melchers WJ, de Pauw BE, Hoogkamp-Korstanje JA, Meis JF. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 1995;33:3150-3.
24. Sanguinetti M, Posteraro B, Pagano L, Pagliari G, Gianchi L, Mele L, La Sorda M, Franco A, Fadda G. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2003;41:3922-5.
25. Stynen D, Sarfati J, Goris A, Prevost MC, Lesourd M, Kamphuis H, Darras V, Latge JP. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 1992;60:2237-45.
26. Rogers TR, Haynes KA, Barnes RA. Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet 1990;336:1210-3.
27. Dupont B, Huber M, Kim SJ, Bennett JE. Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits. J Infect Dis 1987;155:1-11.
28. Haynes KA, Latge JP, Rogers TR. Detection of Aspergillus antigens associated with invasive infection. J Clin Microbiol 1990;28:2040-4.
29. Bennett JE, Friedman MM, Dupont B. Receptor-mediated clearance of Aspergillus galactomannan. J Infect Dis 1987;155:1005-10.
30. Machetti M, Zotti M, Veroni L, Mordini N, van Lint MT, Bacigalupo A, Paola D, Viscoli C. Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole. Transpl Infect Dis 2000;2:140-4.
31. Verweij PE, Brinkman K, Kremer HP, Kullberg BJ, Meis JF. Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J Clin Microbiol 1999;37:1186-9.
32. Kami M, Ogawa S, Kanda Y, Tanaka Y, Machida U, Matsumura T, Sakamaki H, Hirai H. Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzymelinked immunosorbent assay. Br J Haematol 1999;106:536-7.
33. Maertens J, Verhaegen J, Lagrou K, van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001;97:1604-10.
34. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001;91:311-8.
35. Verweij PE, Dompeling EC, Donnelly JP, Schattenberg AV, Meis JF. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection 1997;25:86-9.
36. Williamson EC, Oliver DA, Johnson EM, Foot AB, Marks DI, Warnock DW. Aspergillus antigen testing in bone marrow transplant recipients. J Clin Pathol 2000;53:362-6.
37. Pazos C, Ponton J, del Palacio A. Contribution of (1 → 3)-Beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005;43:299-305.
38. Francesconi A, Kasai M, Petraitiene R, Petraitis V, Kelaher AM, Schaufele R, Hope WW, Shea YR, Bacher J, Walsh TJ. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol 2006;44:2475-80.
39. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag E, Shah PM, Stevens DA, Walsh TJ. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
40. Maertens J. Galactomannan antigen detection in invasive aspergillosis: test optimisation and impact on patient management. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECC-MID). Nice, France; 2006. p. s278.
41. Patterson TF, Miniter P, Ryan JL, Andriole VT. Effect of immunosuppression and amphotericin b on Aspergillus antigenemia in an experimental model. J Infect Dis 1988;158:415-22.
42. Maurer JR, Tullis DE, Grossman RF, Vellend H, Winton TL, Patterson GA. Infectious complications following isolated lung transplantation. Chest 1992;101:1056-9.
43. Fortun J, Martin-Davila P, Alvarez ME, Sanchezsousa A, Quereda C, Navas E, Barcena R, Vicente E, Candelas A, Honrubia A, Nuno J, Pintado V, Moreno S. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation 2001;71:145-9.
44. Kwak EJ, Husain S, Obman A, Meinke L, Stout J, Kusne S, Wagener MM, Singh N. Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004;42:435-8.
45. Husain S, Kwak EJ, Obman A Wagener MM, Kusne S, Stout JE, McCurry KR, Singh N. Prospective assessment of platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 2004;4:796-802.
46. Pereira CN, del Nero G, Lacaz CS, Machado CM. The contribution of galactomannan detection in the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Mycopathologia 2005;159:487-93.
47. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O, Liu KL, Natarajan-Ame S, Lutz P, Dufour P, Bergerat JP, Candolfi E. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002;20:1898-906.
48. Herbrecht R, Moghaddam A, Mahmal L, Natarajaname A, Fornecker LM, Letscher-Bru V. Invasive aspergillosis in the hematologic and immunologic patient: new findings and key questions in leukemia. Med Mycol 2005;43 Suppl 1:s239-42.
49. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006;42:1417-727.
50. Balloy V, Huerre M, Latge JP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005;73:494-503.
51. Mennink-Kersten MA, Donnelly JP, Verweij PE. Retection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004;4:349-57.
52. Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine (Baltimore) 1999;78:123-38.
53. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004;190:641-9.
54. Petraitis V, Petraitiene R, Sarafandi AA, Kelaher AM, Lyman CA, Casler HE, Sein R, Groll AH, Bacher J, Avila NA, Walsh TJ. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis 2003;187:1834-43.
55. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005;40:1762-9.
56. Verweij PE, Masson C, Klont R, Heinen C, Crepin B, Maertens J. Optimisation of the cut-off value of the Platelia Aspergillus ELISA. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Nice, France; 2006. p. s277.
57. Racil Z, Kocmanova I, Kubicova E, Lochmanova J, Sevcikova A, Mayer J. Variation of galactomannan level during 24-hour period in haematooncological patients with/without invasive aspergillosis. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Nice; 2006. p. 729.
58. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005;5:609-22.
59. Maertens J, Theunissen K, Deeren D, Meersseman W, van Eldere J. Defining a case of invasive aspergillosis by serum galactomannan. Med Mycol 2006;44 Suppl:173-8.
60. Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect 2006;12:1060-76.
61. Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M, Eldere JV. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004;126:852-60.
62. Ansorg R, van den Boom R, Rath PM. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 1997;40:353-7.
63. Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004;38:917-20.
64. Mattei F, Rapezzi D, Mordini N, Cuda F, Lo Nigro C, Musso M, Arnelli A, Cagnassi S, Gallamini A. Falsepositive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment. J Clin Microbiol 2004;42:5362-3.
65. Viscoli C, Machetti M, Cappellano P, Bucci B, Bruzzi P, Van Lint MT, Bacigalupo A. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004;38:913-6.
66. Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003;349:2366-7.
67. Bart-Delabesse E, Basile M, Al Jijakli A, Souville D, Gay F, Philippe B, Bossi P, Danis M, Vernant JP, Datry A. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of Beta-lactam treatments. J Clin Microbiol 2005;43:5214-20.
68. Yucesoy M, Ergon MC. Detection of Aspergillus galactomannan antigen levels for antimicrobial agents by ELISA. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Nice, France; 2006: Poster 869.
69. Singh N, Obman A, Husain S, Aspinall S, Mietzner S, Stout JE. Reactivity of Platelia Aspergillus galactomannan antigen with piperacillin- tazobactam: clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother 2004;48:1989-92.
70. Machetti M, Majabo MJ, Furfaro E, Solari N, Novelli A, Cafiero F, Viscoli C. Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis. J Antimicrob Chemother 2006;58:806-10.
71. Aubry A, Porcher R, Bottero J, Touratier S, Leblanc T, Brethon B, Rousselot P, Raffoux E, Menotti J, Derouin F, Ribaud P, Sulahian A. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with Beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 2006;44:389-94.
72. Rohrlich P, Sarfati J, Mariani P, Duval M, Carol A, Saint-Martin C, Bingen E, Latge JP, Vilmer E. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996;15:232-7.
73. Rollides E. Early diagnosis of invasive aspergillosis in small children. 2nd advances against aspergillosis (AAA). Greece, Athens; 2006.
74. Siemann M, Koch-Dorfler M, Gaude M. False-positive results in premature infants with the Platelia Aspergillus sandwich enzyme-linked immunosorbent assay. Mycoses 1998;41:373-7.
75. Mennink-Kersten MA, Klont RR, Warris A, Op den Camp HJ, Verweij PE. Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection. Lancet 2004;363:325-7.
76. Letscher-Bru V, Cavalier A, Pernot-Marino E, Koenig H, Eyer D, Waller J, Candolfi E. Aspergillus galactomannan antigen detection with platelia Aspergillus: multiple positive antigenemia without Aspergillus infection. L Mycologie Medicale 1998;8:112-3.
77. El Saleeby CM, Allison KJ, Knapp KM, Walsh TJ, Hayden RT. Discordant rise in galactomannan antigenemia in a patient with resolving aspergillosis, renal failure, and ongoing hemodialysis. J Clin Microbiol 2005;43:3560-3.
78. Hamaki T, Kami M, Kanda Y, Miyakoshi S, Ueyama J, Morinaga S, Mutou Y. False-positive results of Aspergillus enzyme-linked immunosorbent assay in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001;28:633-4.
79. Muquim A, Dial S, Menzies D. Invasive aspergillosis in patients with chronic obstructive pulmonary diseases. Can Respir J 2005;12:199-204.
80. Calle F, Lopez J, Caillot D, Cuisenier B, Ecarnot LA, Dumont L, Bonnin A. False-positive results caused by cotton swabs in commercial Aspergillus antigen latex agglutination test. Eur J Clin Microbiol Infect Dis 2002;21:130-2.
81. Boutboul F, Alberti C, Leblanc T, Sulahian A, Gluckman E, Derouin F, Ribaud P. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis 2002;34:939-43.
82. Pazos C, del Palacio A. Early diagnosis of invasive aspergillosis in neutropenic patients with bi-weekly serial screening of circulating galactomannan by Platelia Aspergillus. Rev Iberoam Micol 2003;20:99-102.
83. Maertens J, Glasmacher A, Selleslag D, Ngai A, Ryan D, Layton M, Raylor A, Sable C, Kartsonis N. Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study. Clin Infect Dis 2005;41:e9-e14.
84. Klont RR, Mennink-Kersten MA, Ruegebrink D, Rijs AJ, Blijlevens NM, Donnelly JP, Verweij PE. Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis. Clin Infect Dis 2006;43:e23-e25.
85. Chabot J, Twumasi-Boateng K, Patterson TF, Chiang LY, Filler SG, Sheppard DC. Effect of antifungal agents on galactomannan release. 2nd advances against aspergillosis (AAA). Athens, Greece; 2006: Poster 137.
86. Giacchino M, Chiapello N, Bezzio S, Fagioli F, Saracco P, Alfarano A, Martini V, Cimino G, Martino P, Girmenia C. Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum. J Clin Microbiol 2006;44:3432-4.
87. Dalle F, Charles PE, Blanc K, Caillot D, Chavanet P, Dromer F, Bonnin A. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is crossreactive with Aspergillus galactomannan. J Clin Microbiol 2005;43:2929-31.
88. Rimek D, Zimmermann T, Hartmann M, Prariyachatigul C, Kappe R. Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany. Mycoses 1999;42 Suppl 2:25-8.